Global Automated Nucleic Acid Extraction Machine Market Strategic Research Report

Scope of the Report

The global Automated Nucleic Acid Extraction Machine market size is predicted to grow from US$ 856 million in 2025 to US$ 1,319 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

In 2025, global Automated Nucleic Acid Extraction Machine production reached approximately 19,000 units，with an average global market price of around US$ 45,000 per unit, and a gross profit margin of approximately 20%-40%. Automated Nucleic Acid Extraction Machines are laboratory instruments used to automatically extract and purify DNA or RNA from blood, swabs, saliva, tissues, cells, pathogens, and other biological samples. These machines commonly use magnetic bead, membrane column, or automated liquid handling technologies to improve extraction consistency, reduce manual operation, and support downstream PCR, qPCR, sequencing, genotyping, pathogen detection, oncology testing, and molecular diagnostics. Compared with manual extraction methods, automated systems provide higher throughput, better reproducibility, lower contamination risk, shorter processing time, and stronger suitability for clinical laboratories, research laboratories, biopharmaceutical production, and public health testing. The industrial chain of Automated Nucleic Acid Extraction Machines includes upstream magnetic beads, extraction reagents, plastic cartridges, pipette tips, motors, pumps, magnetic rods, heating modules, sensors, control boards, software, robotic modules, and laboratory consumables. The midstream includes instrument design, liquid handling integration, magnetic separation module development, temperature control, software programming, assembly, calibration, contamination control testing, quality inspection, and certification. Downstream applications include hospitals, diagnostic laboratories, disease control centers, research institutes, biopharmaceutical companies, forensic laboratories, veterinary laboratories, food safety laboratories, and contract testing organizations. Related services include installation, training, reagent matching, maintenance, software upgrades, calibration, spare parts supply, and after-sales technical support.

Global key Automated Nucleic Acid Extraction Machine players cover Roche, Thermo Fisher Scientific, Qiagen, Promega, Hain Lifescience, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automated Nucleic Acid Extraction Machine market?

What factors are driving Automated Nucleic Acid Extraction Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automated Nucleic Acid Extraction Machine market opportunities vary by end market size?

How does Automated Nucleic Acid Extraction Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Automated Nucleic Acid Extraction Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Benchtop
• Floor-standing
• Others

Segment by Throughput

• Low Throughput
• Med Throughput
• High Throughput

Segment by Application

• Hospital
• Laboratory
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automated Nucleic Acid Extraction Machine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Laboratory, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact